Boris Jordan, Sonic AI

Skip to content

Home Discover Library Ask Sonic Projects

Use with Claude or ChatGPT

Home Discover Library Ask Sonic Projects

Use with Claude or ChatGPT

Boris Jordan, Sonic AI

Home/Library/Boris Jordan

B

Boris Jordan

Chairman, CEO, and Co-founder, Curaleaf Holdings · Person

14

Mentions

1

Episodes

14

Claims

Boris Jordan - Chairman, CEO, and Co-founder, Curaleaf Holdings. Tracked across 14 mentions in podcasts and expert conversations analyzed by Sonic.

What Boris Jordan has said

Cannabis was first classified as a Schedule 1 drug 55 years ago under the administration of President Richard Nixon.

neutral·Boris Jordan

Curaleaf has a research partnership with the University of Pennsylvania Medical Center.

neutral·Boris Jordan

Boris Jordan predicts that Curaleaf will likely be able to uplist to a major U.S. stock exchange within the next two years.

bullish·Boris Jordan

Cannabis was first classified as a Schedule 1 drug 55 years ago under the administration of President Richard Nixon.

Expert perspectiveBoris JordanApr 24

Curaleaf has a research partnership with the University of Pennsylvania Medical Center.

Expert perspectiveBoris JordanApr 24

Boris Jordan predicts that Curaleaf will likely be able to uplist to a major U.S. stock exchange within the next two years.

SpeculativeBoris JordanApr 24

The reclassification of cannabis to Schedule 3 will allow companies to conduct research with medical institutions and receive federal grants for that research in the United States.

Expert perspectiveBoris JordanApr 24

Curaleaf has completed Phase 1 clinical trials in the United Kingdom for a cannabis-based neuropathic medication and is now advancing to Phase 2.

Expert perspectiveBoris JordanApr 24

An Administrative Law Judge (ALJ) hearing concerning the rescheduling of adult-use cannabis, which was halted during the Trump administration, is scheduled to restart on June 29th.

Expert perspectiveBoris JordanApr 24

U.S. Treasury Secretary Janet Yellen has expressed support for major banking institutions providing services to the cannabis sector.

Expert perspectiveBoris JordanApr 24

Boris Jordan predicts that full federal legalization of cannabis in the United States will likely occur within the next two to three years.

SpeculativeBoris JordanApr 24

Curaleaf is the only major global cannabis company that trades on the Toronto Stock Exchange (TSX).

Expert perspectiveBoris JordanApr 24

Curaleaf is actively engaged in M&A discussions with multiple regional and larger companies in both Europe and the United States.

Expert perspectiveBoris JordanApr 24

Institutional investors including BlackRock and Fidelity participated in Curaleaf's 2018 IPO but later exited their positions after then-Attorney General Jeff Sessions rescinded the Cole Memorandum.

Expert perspectiveBoris JordanApr 24

The reclassification of cannabis to Schedule 3 will eliminate a tax that amounted to approximately 72% of gross margin for cannabis companies.

Expert perspectiveBoris JordanApr 24

65% of Curaleaf's business is conducted through online sales.

Expert perspectiveBoris JordanApr 24

Public polling indicates that support for cannabis legalization in the U.S. is nearly 80% among Democrats and between 59% and 60% among Republicans.

Expert perspectiveBoris JordanApr 24

Create a free account to see Boris Jordan's full intelligence report - every claim, the relationship network, and AI Q&A across all sources. No card needed.

Get started free

Back to Entities Entity Detail